Lanamont

Buspirone Hydrochloride, the active ingredient in Lanamont, is an azapirone presented as an oral formulation for oral use. It is prescribed for generalized anxiety disorder in adult patients, helping to alleviate excessive worry and tension. The medication is manufactured under strict quality standards and is available in tablet form for convenient daily administration.

GNH USA supplies Lanamont as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to Good Distribution Practice, ensuring product integrity during storage and transport across global markets.

Buspirone Hydrochloride is indicated for the treatment of anxiety‑related conditions, primarily within the generalized anxiety disorder spectrum.

- Generalized anxiety disorder: reduces anxiety symptoms and improves daily functioning in adult patients

Buspirone Hydrochloride may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Dizziness - Headache - Nausea - Somnolence - Blurred vision - Constipation

Serious or Rare Side Effects: - Serotonin syndrome (rare) - Severe allergic reaction (anaphylaxis) - Mood changes, including depression or suicidal thoughts - Cardiac arrhythmia (rare)

When prescribing Buspirone Hydrochloride, clinicians should consider several precautionary measures to ensure patient safety.

- Assess psychiatric history: evaluate for depression or suicidal ideation before initiating therapy. - Avoid abrupt discontinuation: taper dose to prevent withdrawal symptoms. - Monitor liver function: adjust if hepatic impairment is present. - Caution in elderly: start with lower dose due to increased sensitivity. - Store at ambient temperature: keep below 25°C in original packaging, protect from moisture.

Buspirone Hydrochloride can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): concurrent use may precipitate hypertensive crisis. - Selective serotonin reuptake inhibitors (SSRIs) and other serotonergic agents: increase risk of serotonin syndrome. - CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): raise buspirone plasma levels. - Alcohol: may enhance central nervous system depression.

Moderate Interactions (Monitor Closely): - CYP3A4 inducers (e.g., rifampin, carbamazepine): may reduce effectiveness. - Antihypertensives: buspirone may potentiate blood pressure‑lowering effects. - Anticholinergic drugs: may increase anticholinergic burden.